TWEAK stimulation of astrocytes and the proinflammatory consequences - PubMed (original) (raw)
Affiliations
- PMID: 10975915
TWEAK stimulation of astrocytes and the proinflammatory consequences
P Saas et al. Glia. 2000 Oct.
Abstract
Astrocytes exert many active roles in brain homeostasis, potentially including the regulation of immune reactions. They possess a substantial aptitude for plasticity and, indeed, functional and phenotypic changes are frequently encountered in reactive gliosis observed in brain injuries. The significance of reactive astrocytes is still poorly defined, but it is clear that these cells are an important source of cytokines in inflamed brain. How tumor necrosis factor (TNF) and TNF-receptor family members contribute to this reaction is an interesting issue that is currently being explored. It was previously shown that reactive astrocytes express high levels of Fas (CD95) and respond to Fas ligand (CD95L) by apoptosis or IL-8 production. TWEAK (Apo-3 ligand) is a recently identified member of the TNF family that is produced mainly by leukocytes that can infiltrate the inflamed brain and thus influence astrocyte behavior. Here we show that human astrocytes derived from different regions of the brain specifically bind TWEAK and are totally resistant to TWEAK mediated apoptosis. In addition, high amounts of IL-8 and IL-6 were secreted by astrocytes after TWEAK exposure. Finally, expression of cell surface molecules involved in the propagation and/or maintenance of brain inflammation was determined. TWEAK significantly increased ICAM-1 expression on astrocytes, whereas no modification was detected in the expression of Fas, TNFRI, B7-1, or MHC molecules. In conclusion, the proinflammatory effects induced by TWEAK on astrocytes in culture recapitulate many characteristics of reactive astrocytes observed in vivo, suggesting that TWEAK could play a significant role in brain inflammation.
Copyright 2000 Wiley-Liss, Inc.
Similar articles
- CD95 (Fas/Apo-1) as a receptor governing astrocyte apoptotic or inflammatory responses: a key role in brain inflammation?
Saas P, Boucraut J, Quiquerez AL, Schnuriger V, Perrin G, Desplat-Jego S, Bernard D, Walker PR, Dietrich PY. Saas P, et al. J Immunol. 1999 Feb 15;162(4):2326-33. J Immunol. 1999. PMID: 9973511 - Proinflammatory effects of tumour necrosis factor-like weak inducer of apoptosis (TWEAK) on human gingival fibroblasts.
Hosokawa Y, Hosokawa I, Ozaki K, Nakae H, Matsuo T. Hosokawa Y, et al. Clin Exp Immunol. 2006 Dec;146(3):540-9. doi: 10.1111/j.1365-2249.2006.03233.x. Clin Exp Immunol. 2006. PMID: 17100776 Free PMC article. - TWEAK/Fn14 interaction stimulates human bronchial epithelial cells to produce IL-8 and GM-CSF.
Xu H, Okamoto A, Ichikawa J, Ando T, Tasaka K, Masuyama K, Ogawa H, Yagita H, Okumura K, Nakao A. Xu H, et al. Biochem Biophys Res Commun. 2004 May 28;318(2):422-7. doi: 10.1016/j.bbrc.2004.04.036. Biochem Biophys Res Commun. 2004. PMID: 15120617 - Regulation of preproenkephalin expression in astrocytes: is there a role for glia-derived opioid peptides in reactive gliosis?
McMillian MK, Hong JS. McMillian MK, et al. Crit Rev Neurobiol. 1994;9(1):91-103. Crit Rev Neurobiol. 1994. PMID: 8828005 Review. - Death receptors on reactive astrocytes: a key role in the fine tuning of brain inflammation?
Dietrich PY, Walker PR, Saas P. Dietrich PY, et al. Neurology. 2003 Feb 25;60(4):548-54. doi: 10.1212/01.wnl.0000042049.74547.7f. Neurology. 2003. PMID: 12607528 Review.
Cited by
- TNF-like weak inducer of apoptosis promotes blood brain barrier disruption and increases neuronal cell death in MRL/lpr mice.
Wen J, Doerner J, Weidenheim K, Xia Y, Stock A, Michaelson JS, Baruch K, Deczkowska A, Gulinello M, Schwartz M, Burkly LC, Putterman C. Wen J, et al. J Autoimmun. 2015 Jun;60:40-50. doi: 10.1016/j.jaut.2015.03.005. Epub 2015 Apr 22. J Autoimmun. 2015. PMID: 25911200 Free PMC article. - Does inflammation after stroke affect the developing brain differently than adult brain?
Vexler ZS, Yenari MA. Vexler ZS, et al. Dev Neurosci. 2009;31(5):378-93. doi: 10.1159/000232556. Epub 2009 Aug 11. Dev Neurosci. 2009. PMID: 19672067 Free PMC article. Review. - Proinflammatory activity of TWEAK on human dermal fibroblasts and synoviocytes: blocking and enhancing effects of anti-TWEAK monoclonal antibodies.
Chicheportiche Y, Chicheportiche R, Sizing I, Thompson J, Benjamin CB, Ambrose C, Dayer JM. Chicheportiche Y, et al. Arthritis Res. 2002;4(2):126-33. doi: 10.1186/ar388. Epub 2001 Nov 9. Arthritis Res. 2002. PMID: 11879548 Free PMC article. - sTWEAK is a leukoaraiosis biomarker associated with neurovascular angiopathy.
da Silva-Candal A, Custodia A, López-Dequidt I, Rodríguez-Yáñez M, Alonso-Alonso ML, Ávila-Gómez P, Pumar JM, Castillo J, Sobrino T, Campos F, Iglesias-Rey R, Hervella P. da Silva-Candal A, et al. Ann Clin Transl Neurol. 2022 Feb;9(2):171-180. doi: 10.1002/acn3.51502. Epub 2022 Jan 21. Ann Clin Transl Neurol. 2022. PMID: 35060359 Free PMC article. - The TWEAK-Fn14 system as a potential drug target.
Wajant H. Wajant H. Br J Pharmacol. 2013 Oct;170(4):748-64. doi: 10.1111/bph.12337. Br J Pharmacol. 2013. PMID: 23957828 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials
Miscellaneous